display:none
Skip to main content

Healthcare 2030: DiMe’s Blueprint to Transform Healthcare

Get involved in an upcoming DiMe project

DiMe Generated Content

Developed with funding from the U.S. Food and Drug Administration (FDA), the Navigator organizes the growing body of regulatory guidance, scientific standards, and industry best practices into a single, centralized platform. The resource represents over a decade of innovative work across industry, academia, and regulatory authorities, distilled into an experience that can be accessed in minutes, reducing the need for teams to independently search across hundreds of sources to piece together relevant regulatory science and guidance.

The Digital Medicine Society (DiME) launched a new set of FDA-aligned digital measures to standardize how outcomes are tracked in pediatric rare disease trials. The framework aims to make trials faster and more efficient, giving researchers and drugmakers a practical roadmap for developing new therapies for children who often have no effective treatment options.

The company announced its support for the Digital Medicine Society (DiMe) DATAcc project, which is launching open-access digital measures aimed at accelerating pediatric rare disease research and care. The initiative, highlighted in a January 29 webinar, seeks to reduce friction in research processes and speed the development and delivery of therapies for children with rare diseases, leveraging digital health and AI in healthcare.

Scaling AI Care Navigation: DiMe announced its first new initiative of the year, bringing together health systems, payors, patient groups, and tech companies to define what “good” looks like for AI-enabled care journeys in the real world. The project is on the lookout for partners to help develop frameworks for evaluating AI navigation tools and ensuring they’re grounded in real operational constraints and evidence from real patients. The final resources will be open sourced and include implementation roadmaps to drive immediate value across the industry.

Digital Medicine Society’s (DiMe) initiative to scale “Trusted AI Care Navigation,” suggesting that the industry is finally moving toward a standard where AI agents are viewed as legitimate partners in the care journey.

The Digital Medicine Society (DiMe) is convening a multi-stakeholder initiative to accelerate the responsible adoption of AI-enabled care navigation at scale.

This work on AI-enabled patient navigation is the first of DiMe’s 2026 portfolio of AI projects, with an initiative to operationalize AI governance launching later this quarter.
Patients are turning to AI to manage care navigation challenges because the health system leaves them little choice, DiMe said, but the solutions and processes available today are far from optimized. At the same time, health systems and payers are under pressure to do more with fewer resources, while patients continue to bear the consequences when care coordination breaks down.

The Digital Medicine Society (DiMe) has launched a new multi-stakeholder initiative, “Scaling Trusted, High-Impact AI Care Navigation,” to accelerate the responsible adoption of AI tools that help patients manage appointments, referrals, and insurance.

Led by title sponsor Intel and a founding coalition of tech and healthcare leaders, the project will develop open-access resources to ensure AI-enabled care journeys are patient-centered, equitable, and grounded in real-world evidence.

Health care in the United States is full of gaps: a doctor failed to notice a patient is taking contraindicated drugs, no one told a patient to get their blood work done three days before surgery, a clinician was too busy to follow up on patient test results.

Some experts think artificial intelligence can fill those gaps in care and the Digital Medicine Society wants to show how it can be done.

DiME, a nonprofit organization that issues guidance and certifications for digital health products, announced on Thursday that it will release a playbook for putting AI to use for patient care by October.

Jennifer Goldsack, CEO of the Digital Medicine Society, outlines DiMe’s new project focused on aging-in-place with healthcare technologies and reimbursing remote patient monitoring as federal and private insurers’ coverage policies evolve.

“If we don’t get implementation right, and if we don’t take it to scale, I don’t know what the sustainable future of the healthcare industry is… why any investor would continue to invest into healthcare AI if we can’t take it to scale.”
-DiMe CEO Jennifer Goldsack

The Digital Medicine Society launched a new initiative — it seeks to establish a roadmap for how technology can support older adults who want to age safely at home. The project will bring together health systems, home health agencies and tech companies to develop products, policy guidance and case studies for scalable home care.

Digital Medicine Society — also known as DiMe — has initiated a collaborative project with the Consumer Technology Association and a coalition of industry partners. The partners aim to create a structured framework to support elderly individuals who wish to continue living in their own residences.

Healthtech and edtech are two of the fastest growing sectors, with the healthtech market size to reach $3.1 billion by 2033, while the global education technology market size is projected to reach $348.41 billion by 2030.

Health systems and tech companies like Epic are teaming up to advance care at home with digital solutions.

DiMe’s new initiative brings together home care companies, connected device manufacturers, health tech companies, medical equipment supplies, health systems and payers.

Join our next project

Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients

Join the Integrated Evidence Plans project

Join us
Not today